BioHarvest Sciences Statistics
Total Valuation
BHST has a market cap or net worth of $100.19 million. The enterprise value is $91.26 million.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BHST has 22.67 million shares outstanding. The number of shares has increased by 13.69% in one year.
| Current Share Class | 22.67M |
| Shares Outstanding | 22.67M |
| Shares Change (YoY) | +13.69% |
| Shares Change (QoQ) | +22.71% |
| Owned by Insiders (%) | 14.78% |
| Owned by Institutions (%) | 7.37% |
| Float | 17.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.90 |
| Forward PS | n/a |
| PB Ratio | 3.94 |
| P/TBV Ratio | 3.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.97, with a Debt / Equity ratio of 0.55.
| Current Ratio | 3.97 |
| Quick Ratio | 3.29 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.05 |
Financial Efficiency
Return on equity (ROE) is -83.17% and return on invested capital (ROIC) is -12.74%.
| Return on Equity (ROE) | -83.17% |
| Return on Assets (ROA) | -9.59% |
| Return on Invested Capital (ROIC) | -12.74% |
| Return on Capital Employed (ROCE) | -13.94% |
| Weighted Average Cost of Capital (WACC) | 12.34% |
| Revenue Per Employee | $387,730 |
| Profits Per Employee | -$125,112 |
| Employee Count | 89 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 3.42 |
Taxes
In the past 12 months, BHST has paid $76,000 in taxes.
| Income Tax | 76,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.77% in the last 52 weeks. The beta is 1.40, so BHST's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | -21.77% |
| 50-Day Moving Average | 4.43 |
| 200-Day Moving Average | 6.84 |
| Relative Strength Index (RSI) | 54.54 |
| Average Volume (20 Days) | 27,544 |
Short Selling Information
The latest short interest is 64,866, so 0.29% of the outstanding shares have been sold short.
| Short Interest | 64,866 |
| Short Previous Month | 69,290 |
| Short % of Shares Out | 0.29% |
| Short % of Float | 0.36% |
| Short Ratio (days to cover) | 3.47 |
Income Statement
In the last 12 months, BHST had revenue of $34.51 million and -$11.14 million in losses. Loss per share was -$0.60.
| Revenue | 34.51M |
| Gross Profit | 20.48M |
| Operating Income | -5.58M |
| Pretax Income | -11.06M |
| Net Income | -11.14M |
| EBITDA | -5.11M |
| EBIT | -5.58M |
| Loss Per Share | -$0.60 |
Full Income StatementBalance Sheet
The company has $23.04 million in cash and $14.10 million in debt, with a net cash position of $8.93 million or $0.39 per share.
| Cash & Cash Equivalents | 23.04M |
| Total Debt | 14.10M |
| Net Cash | 8.93M |
| Net Cash Per Share | $0.39 |
| Equity (Book Value) | 25.45M |
| Book Value Per Share | 1.12 |
| Working Capital | 22.82M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.23 million and capital expenditures -$2.36 million, giving a free cash flow of -$9.58 million.
| Operating Cash Flow | -7.23M |
| Capital Expenditures | -2.36M |
| Depreciation & Amortization | 464,000 |
| Net Borrowing | 5.09M |
| Free Cash Flow | -9.58M |
| FCF Per Share | -$0.42 |
Full Cash Flow StatementMargins
Gross margin is 59.34%, with operating and profit margins of -16.16% and -32.27%.
| Gross Margin | 59.34% |
| Operating Margin | -16.16% |
| Pretax Margin | -32.05% |
| Profit Margin | -32.27% |
| EBITDA Margin | -14.81% |
| EBIT Margin | -16.16% |
| FCF Margin | n/a |
Dividends & Yields
BHST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.69% |
| Shareholder Yield | -13.69% |
| Earnings Yield | -11.11% |
| FCF Yield | -9.56% |
Analyst Forecast
The average price target for BHST is $10.00, which is 126.24% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 126.24% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 3, 2024. It was a reverse split with a ratio of 1:35.
| Last Split Date | Jun 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:35 |
Scores
BHST has an Altman Z-Score of 1.34 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.34 |
| Piotroski F-Score | 3 |
